MYLK2 Polyklonale Antilichaam, AbBy FluorTM 647 Vervoeging

The Ca2+/calmodulin-dependent protein kinases (CaM kinases) are a structurally related subfamily of serine/threonine kinases that includes CaMKI, CaMKII, CaMKIV and myosin light chain kinases (MYLK, also designated MLCK) . The MYLK kinases phosphorylate myosin regulatory light chains to catalyze myosin interaction with actin filaments resulting in contractile activity. Non-muscle, smooth muscle and skeletal/cardiac muscle MYLK isoforms exist. The MYLK gene (also designated MYLK1) encodes both smooth muscle and non-muscle isoforms as well as telokin, a small C-terminal isoform expressed only in smooth muscle with the capacity to stabilize unphosphorylated myosin filaments. Multiple transcript variants are described for the MYLK gene. Smooth-muscle and non-muscle MYLK isoforms are expressed in a wide variety of adult and fetal tissues. The skeletal/cardiac muscle isoforms of MYLK are encoded by a separate gene, MYLK2 (also designated skMLCK) . MYLK appears to be a target for PAKs (p21-activated kinases) . PAK1 interaction with MYLK results in a decrease in MYLK activity and myosin light chain phosphorylation.

KMLC; MLCK; MLCK2; MYLK 2; Myosin light chain kinase 2; Myosin light chain kinase 2 skeletal muscle; Myosin light chain kinase 2 skeletal/cardiac muscle; Skeletal muscle myosin light chain kinase; Skeletal myosin light chain kinase; skMLCK; MYLK2_HUMAN.

85366

Human, Mouse, Rat

261-360/596

MYLK2

AbBy Fluor™ 647

KLH conjugated synthetic peptide derived from human MYLK2

WB, IF (IHC-P)

Purified by Protein A.

650nm/665nm

1µg/µl

WB (1:300-5000), IF (IHC-P) (1:50-200)

Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Unmodified

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

85366